Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
OraSure Technologies, Inc. OSUR
$6.03
-$1.11 (-18.47%)
На 18:00, 12 мая 2023
Ранг: 2
Ключевые показатели
-
Marketcap
539081728.00000000
-
week52high
7.82
-
week52low
2.62
-
Revenue
387479000
-
P/E TTM
-28
-
Beta
0.07923800
-
EPS
-0.24000000
-
Last Dividend
1.60000000
-
Next Earnings Date
10 мая 2023 г. в 20:05
Описание компании
OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. It operates in two segments, Diagnostics and Molecular Solutions. The company's principal products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D. saliva alcohol test. It also offers genomic products under the Oragene and ORAcollect brands; microbiome collection products; and GenoFIND genomics laboratory services. In addition, the company provides ORAcollect, RNA and OMNIgene, and RAL collection devices for use in connection with COVID-19 molecular testing; offers Colli-Pee collection device for the volumetric collection of first void urine; and manufactures and sells kits that are used to collect, stabilize, transport, and store samples of genetic material for molecular testing in the academic research and commercial applications, including ancestry, disease risk management, lifestyle, and animal testing. Further, it provides other diagnostic products, such as immunoassays and other in vitro diagnostic tests. The company markets its products to clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities. OraSure Technologies, Inc. was incorporated in 2000 and is headquartered in Bethlehem, Pennsylvania.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Citigroup | Buy | Buy | 11 мая 2022 г. |
| Citigroup | Buy | Buy | 24 февр 2022 г. |
| Raymond James | Market Perform | Outperform | 22 сент 2021 г. |
| Raymond James | Outperform | Outperform | 04 авг 2021 г. |
| Raymond James | Outperform | Outperform | 28 июн 2021 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Weber Kathleen Gallagher | D | 228329 | 3234 | 01 февр 2023 г. |
| Weber Kathleen Gallagher | D | 231563 | 1729 | 01 февр 2023 г. |
| Weber Kathleen Gallagher | D | 233292 | 3112 | 01 февр 2023 г. |
| Weber Kathleen Gallagher | D | 236404 | 3705 | 01 февр 2023 г. |
| Weber Kathleen Gallagher | A | 240109 | 13006 | 01 февр 2023 г. |
| Weber Kathleen Gallagher | D | 227103 | 11115 | 01 февр 2023 г. |
| Weber Kathleen Gallagher | A | 238218 | 39016 | 01 февр 2023 г. |
| Anthony Michele Marie | D | 57821 | 766 | 01 февр 2023 г. |
| Anthony Michele Marie | D | 58587 | 385 | 01 февр 2023 г. |
| Anthony Michele Marie | D | 58972 | 853 | 01 февр 2023 г. |
Новостная лента
OraSure Technologies, Inc. (OSUR) Q1 2023 Earnings Call Transcript
Seeking Alpha
10 мая 2023 г. в 22:50
OraSure Technologies, Inc. (NASDAQ:OSUR ) Q1 2023 Earnings Conference Call May 10, 2023 5:00 PM ET Company Participants Scott Gleason - Head of Investor Relations Carrie Manner - President & Chief Executive Officer Ken McGrath - Chief Financial Officer Conference Call Participants Casey Woodring - JPMorgan Operator Good day, and thank you for standing-by. Welcome to the OraSure Technologies Earnings Conference Call.
OraSure Technologies (OSUR) Q1 Earnings and Revenues Beat Estimates
Zacks Investment Research
10 мая 2023 г. в 18:59
OraSure Technologies (OSUR) came out with quarterly earnings of $0.37 per share, beating the Zacks Consensus Estimate of $0.16 per share. This compares to loss of $0.28 per share a year ago.
2023 First Quarter Earnings Conference Call Wednesday, May 10, 2023, 5:00 p.m. ET
GlobeNewsWire
03 мая 2023 г. в 07:05
BETHLEHEM, Pa., May 03, 2023 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering 2023 first quarter financial results and certain business developments for 5:00 p.m. ET (2:00 p.m. PT) on Wednesday, May 10, 2023.
Is OraSure Technologies (OSUR) Outperforming Other Medical Stocks This Year?
Zacks Investment Research
21 апр 2023 г. в 11:25
Here is how OraSure Technologies (OSUR) and Acadia Pharmaceuticals (ACAD) have performed compared to their sector so far this year.
OraSure (OSUR) Stock Jumps 9.3%: Will It Continue to Soar?
Zacks Investment Research
05 апр 2023 г. в 09:54
OraSure (OSUR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.